ATP13A3 silencing also sensitized MYCN‐amplified (KELLY) and non‐MYCN‐amplified (SH‐SY5Y) neuroblastoma cells to escalating DFMO concentrations, which resulted in reduced growth and colony‐forming capabilities (Fig. 7E–H). This evidence concerns the gene ATP13A3 and neuroblastoma.